Global Medical Aesthetics Market - 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	195 Pages	DataM Intelligence 4Market Research LLP	June, 2023	DTAM18020147

Best Price Guarantee
Price	from $4,350
Length	195 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	June, 2023
SKU	DTAM18020147

Global Medical Aesthetics Market - 2023-2030

The Global Medical Aesthetics Market size reached US$ 13.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 32.5 billion by 2030. The market is exhibiting at a CAGR of 11.8% during the forecast period 2023-2030.

The medical aesthetics market is driven by increasing beauty consciousness, the aging population, technological advancements, growing medical tourism, shifting towards preventive aesthetics, and improved safety and efficacy profiles.

The medical aesthetics market has some restraints, such as the high cost of procedures, regulatory environment, side effects associated with medical aesthetics, safety concerns, lack of skilled professionals, social stigma and perception, limited insurance coverage, cultural and ethical considerations, and lack of long-term data on the safety and efficacy of certain treatments and so on.

Market Dynamics

Increasing Beauty Consciousness

The increasing beauty consciousness among individuals has been a significant driver of growth in the medical aesthetics market. There has been a cultural shift towards valuing and investing in personal appearance, with many people seeking to enhance their natural features or address specific aesthetic concerns.

Several factors such as social media and the widespread use of smartphones, advancements in technology, and the availability of minimally invasive or non-invasive procedures influence people's perceptions of attractiveness. Furthermore, the increasing beauty consciousness is a major factor in improving the medical aesthetics market growth.

High Cost of the Procedures

The high cost of medical aesthetics procedures significantly impacts market growth. The cost varies depending on the type of procedure, geographic location, the practitioner’s expertise, and the specific clinic or facility. The high price of medical aesthetics procedures can create barriers to access for some individuals who may find the treatments unaffordable. However, it is important to consider that the cost of these procedures often reflects the quality, expertise, safety measures, and advanced technology involved.

In recent years, the market has witnessed efforts to make medical aesthetics more accessible and affordable. This includes the availability of financing options, package deals, loyalty programs, and the emergence of specialized clinics that offer competitive pricing. Additionally, as the market continues to grow and evolve, advancements and innovations may potentially drive down costs in the future.

COVID-19 Impact Analysis

The COVID-19 pandemic is significantly impacted the medical aesthetics market. Many aesthetic clinics and medical spas were temporarily closed or operated with restrictions during the initial phases of the pandemic. The pandemic brought about changes in consumer priorities and financial situations. The medical aesthetics industry had to adapt to stringent safety and hygiene protocols to minimize the risk of COVID-19 transmission.

As pandemic-related restrictions eased and vaccination campaigns progressed, the medical aesthetics market began to recover. The pent-up demand for aesthetic treatments and the desire to address appearance-related concerns contributed to a resurgence in the market. People sought to refresh their appearance after prolonged remote work, video conferencing, and mask usage. Overall, the market is recovering after the pandemic.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict between the two countries significantly impacted the medical aesthetics market in the region, disrupting healthcare infrastructure, including medical facilities and clinics; medical aesthetics procedures took a backseat as resources and attention were focused on more critical areas of healthcare. Risk about the war's long-term impact on cosmetics and the missed opportunities for research in Ukraine's academic, medical, and scientific disciplines during Russia Ukraine war.

Segment Analysis

The Global Medical Aesthetics Market is segmented based on product, application, end-user, and region.

Skin-tightening Devices in Product Segment will be Dominated in the Market by Capturing 37.1% Market Share During the Forecast Period.

Based on the product, skin-tightening devices are a popular and widely used category within the medical aesthetics market. These devices use various technologies, such as radiofrequency (RF), ultrasound, laser, or infrared, to stimulate collagen production and improve skin firmness and tightness. Skin-tightening treatments are sought by individuals looking to address sagging skin, wrinkles, and overall skin laxity.

Skin-tightening devices offer a non-surgical or minimally invasive alternative to surgical procedures like facelifts. Many prefer these non-invasive options as they involve little to no downtime, carry fewer risks, and do not require incisions or anesthesia. The devices have seen significant advancements in recent years, enhancing their effectiveness and safety. energy delivery, precision targeting, and temperature control have contributed to better treatment outcomes and patient satisfaction.

Geographical Analysis

North America Accounted for Approximately 41.3% of the Market Share in 2022 due to advanced healthcare infrastructure.

North America, particularly the United States, has a well-developed healthcare system with advanced medical facilities and a strong network of clinics, hospitals, and aesthetic centers. These facilities offer a wide range of medical aesthetics treatments and have access to state-of-the-art technologies and equipment.

North America is a hub for technological innovation, including advancements in medical aesthetics. The region has been at the forefront of developing and adopting new technologies, such as laser devices, energy-based treatments, and advanced injectables. These technological advancements attract patients and contribute to the growth of the market.

Competitive Landscape

The major global players in the market include Allergan plc, Alma Lasers Ltd., Cutera Inc., Cynosure, Fotona d.o.o, Merz Pharma GmbH & Co., Sientra Inc., Sinclair Pharma PLC, Syneron Medical Ltd., and Bausch Health Companies Inc.

Why Purchase the Report?
• To visualize the Global Medical Aesthetics Market segmentation based on product, application, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous medical aesthetics market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Global Medical Aesthetics Market Report Would Provide Approximately 54 Tables, 46 Figures And 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope: 1.1. Research Methodology; 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary: 3.1. Snippet by Product; 3.2. Snippet by Application; 3.3. Snippet by End-User; 3.4. Snippet by Region
4. Dynamics: 4.1. Impacting Factors; 4.1.1. Drivers; 4.1.1.1. Increasing beauty consciousness; 4.1.2. Restraints; 4.1.2.1. High cost of the procedure; 4.1.3. Opportunity; 4.1.4. Impact Analysis
5. Industry Analysis: 5.1. Porter's 5 Forces Analysis; 5.2. Supply Chain Analysis; 5.3. Pricing Analysis; 5.4. Regulatory Analysis
6. COVID-19 Analysis: 6.1. Analysis of COVID-19; 6.1.1. Before COVID-19 Scenario; 6.1.2. Present COVID-19 Scenario; 6.1.3. Post COVID-19 or Future Scenario; 6.2. Pricing Dynamics Amid COVID-19; 6.3. Demand-Supply Spectrum; 6.4. Government Initiatives Related to the Market During the Pandemic; 6.5. Manufacturer’s Strategic Initiatives; 6.6. Conclusion
7. By Product: 7.1. Introduction; 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 7.1.2. Market Attractiveness Index, By Product; 7.2. Body Contouring Devices*; 7.2.1. Introduction; 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 7.3. Aesthetic Lasers; 7.4. Skin Tightening Devices; 7.5. Facial Aesthetic Devices; 7.5.1. Botox; 7.5.2. Chemical Peels; 7.5.3. Dermal Fillers; 7.6. Implants; 7.6.1. Breast Implants; 7.6.1.1. Silicone gel-filled Implants; 7.6.1.2. Saline Filled; 7.6.1.3. Cohesive Semi-solid Implants; 7.6.2. Facial Implants; 7.7. Others
8. By Application: 8.1. Introduction; 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 8.1.2. Market Attractiveness Index, By Application; 8.2. Carbon Peel*; 8.2.1. Introduction; 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 8.3. Tattoo Removal; 8.4. Skin Resurfacing; 8.5. Hair Removal; 8.6. Scar Treatment; 8.7. Others
9. By End-User: 9.1. Introduction; 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User; 9.1.2. Market Attractiveness Index, By End-User; 9.2. Hospitals*; 9.2.1. Introduction; 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 9.3. Dermatology Clinics; 9.4. Medical Spas; 9.5. Beauty Centers
10. By Region: 10.1. Introduction; 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region; 10.1.2. Market Attractiveness Index, By Region; 10.2. North America; 10.2.1. Introduction; 10.2.2. Key Region-Specific Dynamics; 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User; 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.2.6.1. The U.S.; 10.2.6.2. Canada; 10.2.6.3. Mexico; 10.3. Europe; 10.3.1. Introduction; 10.3.2. Key Region-Specific Dynamics; 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User; 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.3.6.1. Germany; 10.3.6.2. The UK; 10.3.6.3. France; 10.3.6.4. Italy; 10.3.6.5. Spain; 10.3.6.6. Rest of Europe; 10.4. South America; 10.4.1. Introduction; 10.4.2. Key Region-Specific Dynamics; 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User; 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.4.6.1. Brazil; 10.4.6.2. Argentina; 10.4.6.3. Rest of South America; 10.5. Asia-Pacific; 10.5.1. Introduction; 10.5.2. Key Region-Specific Dynamics; 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User; 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.5.6.1. China; 10.5.6.2. India; 10.5.6.3. Japan; 10.5.6.4. Australia; 10.5.6.5. Rest of Asia-Pacific; 10.6. Middle East and Africa; 10.6.1. Introduction; 10.6.2. Key Region-Specific Dynamics; 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape: 11.1. Competitive Scenario; 11.2. Market Positioning/Share Analysis; 11.3. Mergers and Acquisitions Analysis
12. Company Profiles: 12.1. Allergan plc*; 12.1.1. Company Overview; 12.1.2. Product Portfolio and Description; 12.1.3. Financial Overview; 12.1.4. Key Developments; 12.2. Alma Lasers Ltd.; 12.3. Cutera Inc.; 12.4. Cynosure; 12.5. Fotona d.o.o.; 12.6. Merz Pharma GmbH & Co.; 12.7. Sientra Inc.; 12.8. Sinclair Pharma PLC; 12.9. Syneron Medical Ltd.; 12.10. Bausch Health Companies Inc.; LIST NOT EXHAUSTIVE
13. Appendix: 13.1. About Us and Services; 13.2. Contact Us